Data / Research funding / California / Electronic Biosciences, Inc.
Electronic Biosciences, Inc.: 25 NIH awards ($11M), fiscal years 2021 to 2026
Electronic Biosciences, Inc. in San Diego, CA is funded under 25 NIH awards ($11M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- FLHHE89XH2H5
- State
- California
Awards
25 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Nanoscale Tools for Inosine Sequencing | NIH | National Human Genome Research Institute | 2022 to 2023 | $2,000,000 | July 1, 2022 | June 30, 2025 | ERVIN, ERIC | reporter.nih.gov |
| Controlled Protein Translocation in Nanopores for Sequencing Applications | NIH | National Institute of General Medical Sciences | 2023 to 2024 | $469,799 | July 1, 2023 | June 30, 2025 | PETERSON, ERIC MAYO | reporter.nih.gov |
| Nanopores for Processing Proteins | NIH | National Human Genome Research Institute | 2023 | $407,291 | September 20, 2023 | August 31, 2025 | ERVIN, ERIC | reporter.nih.gov |
| Fingerprinting Cancer via Multiparameter Extracellular Vesicle Analysis | NIH | National Cancer Institute | 2021 | $400,000 | July 1, 2021 | June 30, 2023 | GERMAN, SEAN | reporter.nih.gov |
| Comprehensive Botulinum Characterization via the Bilayer Nanowell Integrated Assay | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $400,000 | March 1, 2022 | February 29, 2024 | ERVIN, ERIC | reporter.nih.gov |
| Exonuclease Based Microsatellite Sequencing | NIH | National Cancer Institute | 2022 | $400,000 | April 12, 2022 | March 31, 2024 | ERVIN, ERIC | reporter.nih.gov |
| Sequencing the Mono-Methylated Derivatives of Cytidine | NIH | National Human Genome Research Institute | 2023 | $400,000 | February 13, 2023 | January 31, 2025 | ERVIN, ERIC | reporter.nih.gov |
| Microsatellite Instability Sequencing via Single-Molecule DNA Re-Reading | NIH | National Cancer Institute | 2023 | $400,000 | September 18, 2023 | March 31, 2025 | SCHIBEL, ANNA | reporter.nih.gov |
| Fourth-Generation Nanopore-Assisted Sequencing for Advanced Oncological Analyses | NIH | National Cancer Institute | 2024 | $400,000 | September 1, 2024 | August 31, 2025 | PETERSON, ERIC MAYO | reporter.nih.gov |
| Next-Generation Cardiovascular Risk Assessments Via State-Of-The-Art Lipoprotein Characterization | NIH | National Heart, Lung, and Blood Institute | 2024 | $400,000 | September 20, 2024 | September 19, 2025 | GERMAN, SEAN | reporter.nih.gov |
| Long-lived Platform Development for Exonuclease-Based Sequencing | NIH | National Human Genome Research Institute | 2021 | $399,999 | September 1, 2021 | August 31, 2023 | ERVIN, ERIC | reporter.nih.gov |
| Dual Reader Protein Sequencing | NIH | National Human Genome Research Institute | 2022 | $394,141 | August 1, 2022 | July 31, 2024 | ERVIN, ERIC | reporter.nih.gov |
| Two readers for RNA | NIH | National Human Genome Research Institute | 2022 | $393,972 | July 20, 2022 | March 19, 2024 | SCHIBEL, ANNA | reporter.nih.gov |
| Controlled Protein Translocation in Nanopores for Sequencing Applications | NIH | National Human Genome Research Institute | 2023 | $393,486 | August 11, 2023 | July 31, 2024 | SCHIBEL, ANNA | reporter.nih.gov |
| TOPIC 455: IDEAL AT-HOME PROSTATE SPECIFIC ANTIGEN (PSA) TESTING | NIH | National Cancer Institute | 2024 | $389,535 | September 16, 2024 | September 15, 2025 | ERVIN, ERIC | reporter.nih.gov |
| Rapid Fingerstick Diagnostics for Opioid and Stimulant Use Disorders | NIH | National Institute on Drug Abuse | 2025 | $386,452 | April 1, 2025 | March 31, 2027 | ERVIN, ERIC | reporter.nih.gov |
| SpinSeq | NIH | National Human Genome Research Institute | 2025 | $383,482 | June 6, 2025 | May 31, 2027 | PETERSON, AMBERLYN MEGAN | reporter.nih.gov |
| The Nanopore-based Ion Selective Electrode Vial | NIH | National Institute of General Medical Sciences | 2021 | $350,000 | September 20, 2021 | September 19, 2023 | GERMAN, SEAN | reporter.nih.gov |
| High-Resolution Pseudouridine and m6A Sequencing Through Advanced Nanopore Adduct Analysis | NIH | National Institute of General Medical Sciences | 2025 | $350,000 | June 1, 2025 | May 31, 2027 | ERVIN, ERIC | reporter.nih.gov |
| Direct Proteolytic Machine Assessments for Unfolding and Sequencing Proteins | NIH | National Institute of General Medical Sciences | 2025 | $350,000 | June 5, 2025 | May 31, 2027 | GERMAN, SEAN | reporter.nih.gov |
| Nanopore Array for Multiparameter Analysis of Single Extracellular Vesicles | NIH | National Institute of General Medical Sciences | 2023 | $349,996 | September 20, 2023 | October 19, 2024 | GERMAN, SEAN | reporter.nih.gov |
| Re-Reading RNA to Obtain High Accuracy | NIH | National Human Genome Research Institute | 2024 | $347,026 | April 23, 2024 | January 22, 2026 | SCHIBEL, ANNA | reporter.nih.gov |
| Point-of-Care Multiplexed Immunosuppressant Monitoring | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $300,000 | August 10, 2023 | July 31, 2025 | SCHIBEL, ANNA | reporter.nih.gov |
| Point-of-Care Assay for Type 1 Diabetes Diagnosis and Prognostication | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $284,517 | September 1, 2023 | August 31, 2025 | ERVIN, ERIC | reporter.nih.gov |
| Precise Length and 5-Methylcytosine Assessments of Repeat Sequences | NIH | National Human Genome Research Institute | 2021 | $271,933 | May 10, 2021 | April 30, 2023 | SCHIBEL, ANNA | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 4 | $1,469,934 | 0 | $0 |
| 2024 | 5 | $1,755,616 | 0 | $0 |
| 2023 | 9 | $3,786,034 | 0 | $0 |
| 2022 | 5 | $2,588,113 | 0 | $0 |
| 2021 | 4 | $1,421,932 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Bioengineering
- Nanotechnology
- Biotechnology
- Genetics
- Human Genome
- Cancer
- Precision Medicine
- Prevention
- Women's Health
- Cancer Genomics
- Brain Disorders
- Neurosciences
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.